• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC QUANTUM APEX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC QUANTUM APEX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 6530
Medical Device Problem Codes Failure to Advance (2524); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/10/2023
Type of Reportable Event Malfunction
Event or Problem Description
Reportable based on device analysis completed on (b)(6) 2025.It was reported that crossing difficulties occurred.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified mid left anterior descending artery (lad).An 8mm x 3.50mm nc quantum apex mr was advanced for pre-dilation but failed to cross the angulated lesion.The procedure was completed with another smaller sized balloon catheter.No patient complications were reported.However, returned device analysis revealed that the balloon tear.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: a microscopic examination of balloon profile revealed 1mm tear was noted on the balloon.The tear was 1mm distal to distal markerband.Visual and tactile examination of the hypotube shaft, outer / mid-shaft sections or the inner lumen of the device identified no issues.Microscopic examination of the proximal, distal markerbands and tip identified no damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC QUANTUM APEX
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key23498291
Report Number2124215-2025-78222
Device Sequence Number21110968
Product Code LOX
UDI-Device Identifier08714729783176
UDI-Public08714729783176
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K121667
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/06/2025
Device Model Number6530
Device Catalogue Number6530
Device Lot Number0030302883
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/30/2025
Initial Report FDA Received Date11/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/07/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient Age55 YR
Patient SexMale
Patient RaceAsian
-
-